Search
for
Sort by
Research 961–990 of 1000+
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Matrix Metalloproteinase-19 Expression in Normal and Diseased Skin: Dysregulation by Epidermal Proliferation
- The Human Skin Microbiome in Selected Cutaneous Diseases
- Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
- Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases
- Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification
- Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements
- Enter the Matrix: Fibroblast-immune cell interactions shape extracellular matrix deposition in health and disease.
- Frontal Fibrosing Alopecia: Successfully Treated with Methotrexate or Just the Natural Disease Progression?
- The Roles of EDA2R in Ageing and Disease
- Platelet-Rich Plasma and Combination Therapies for Dry Eye Disease: Current Advances and Future Directions
- Multidisciplinary screening and diagnosis of obesity related diseases: an Arabic Association for the Study of Diabetes and metabolism position statement (AASD)
- Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Miscellaneous Exogenous Hormones and Breast Diseases: A Matter of Concern for the Gynecologist
- Sperling LC, Cowper SE, Knopp EA. An Atlas of Hair Pathology with Clinical Correlations. Second edition. New York & London: Informa Healthcare, 2012
- Lichen planopilaris versus frontal fibrosing alopecia: histopathologically distinct diseases or not?
- Could the Risk of Chronic Degenerative Valve Disease (CDVD) in Dogs Depend on Exposure to Endocrine-Disrupting Chemicals Polluting the Environment?
- Exosomal microRNA-Based therapies for skin diseases
- Probiotics: An Adjuvant therapy for D-Galactose induced Alzheimer's disease
- Molecular Genetics of Human Hair Diseases
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment
- Volatile organic compounds: A proinflammatory activator in autoimmune diseases
- Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis
- The expanding significance of keratin intermediate filaments in normal and diseased epithelia
- Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Activation of Nrf2 in keratinocytes causes chloracne (MADISH)‐like skin disease in mice